Patent · US Active

Serum albumin binding immunoglobulin single variable domains

US11414480B2 · kind B2 · utility

3Cited by

0References

20Claims

0Family size

Assignee

Ablynx N.V. · BE

Inventors

Stephanie Staelens · Wevelgem, BE
Soren Steffensen · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
Erika Morizzo · Wondelgem, BE
Raf Ponsaerts · Kampenhout, BE
Ingrid Ottevaere · Nazareth, BE
An Cerdobbel · Nevele, BE

Key dates

Filing date	Dec 7, 2017
Grant date	Aug 16, 2022
Priority date	—
Expiry date	Dec 30, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to amino acid sequences that can bind to serum albumin. In particular, the present invention relates to immunoglobulin single variable domains, and in particular heavy-chain immunoglobulin single variable domains, that can bind to serum albumin. The invention also relates to proteins, polypeptides and other constructs, compounds, molecules or chemical entities that comprise at least one of the immunoglobulin single variable domains binding to serum albumin that are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.